Clinical Trials Directory

Trials / Unknown

UnknownNCT03952169

Effect of Probiotics on Lipid Management

Role of Probiotics in the Management of Hypercholesterolemia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

Dysbiosis of gut microbiota has been reported to be involved in the development of hypercholesterolemia in both humans and animal models. Probiotics have been reported to have ameliorative effects in murine models. However, whether probiotics could help alleviate dyslipidemia in adults remain obscure.

Detailed description

Probiotics are live microorganisms that have been associated with multiple health benefits. However, its protective role in adults has long been controversial. This study aims to examine the effect of 12-week probiotics supplementation on lipid management in Chinese adults. By understanding the mechanism by which probiotics exert the beneficial effects, we can better control the rising prevalence of hypercholesterolemia, which is a major risk factor for cardiovascular diseases.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLactobacillus paracasei dietary supplementa commercial probiotic dietary supplement
OTHERPlacebo controlsplacebo with a similar appearance to probiotics supplement

Timeline

Start date
2019-05-12
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2019-05-16
Last updated
2022-05-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03952169. Inclusion in this directory is not an endorsement.